Dergiler / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

Hyperpigmented mycosis fungoides: A case report

Sayfa
416–418
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A case of mycosis fungoides is presented to increase awareness of this rare disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:A sixty-six-years old male patient was evaluated in the dermatology outpatient clinic with extensive hyperpigmented macules and two tumoral lesions approximately three cm diameter around the umblicus.
📊
Temel Bulgular & Veri:However, as the complaints increased, a diagnosis of mycosis fungoides was made as a result of a skin biopsy.
💡
Sonuç & Katkı:A case of mycosis fungoides is presented to increase awareness of this rare disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

A sixty-six-years old male patient was evaluated in the dermatology outpatient clinic with extensive hyperpigmented macules and two tumoral lesions approximately three cm diameter around the umblicus. Antimycotic and corticosteroid treatment was administered. However, as the complaints increased, a diagnosis of mycosis fungoides was made as a result of a skin biopsy. Six cures of single- agent gemcitabine chemotherapy were administered by the hematology outpatient clinic and a complete response was obtained. A case of mycosis fungoides is presented to increase awareness of this rare disease.

🔖

Bu Makaleye Atıf Yap

KORKMAZ, S., EREN, D., KUM, A., FIRAT, E., ELMAAĞAÇ, M., TEKİN, Y. (2022). Hyperpigmented mycosis fungoides: A case report. Medicine Science, Cilt: 11 - Sayı: 1, 416–418. https://ajindex.com/articles/579731

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Lauren C Pinter-Brown, Emmanuel C Besa. Cutaneus T-Cell Lymphoma. WebMD. 2011;3:236-9
  2. Hoppe RT, Wood GS, Abel EA. Mycosis Fungoides and Sezary Syndrome: Pathology, staging, and treatment. Curr Probl Cancer. 1990;1:293-5
  3. Sanjay Vinjamaram, Emmanuel C Besa. Lymphoma Non-Hodgins. WebMD 2011; 2:1-4.3
  4. Joseph M. Connors, Erick D, Francine M. Foss. Lymphoma of the Skin. Am Society Hematology. 2012;1:263-78
  5. Elder D, Elenitsas R, Jaworsky C, et al. Lever's histopathology of the skin. New York. Lippincott raven Press. 1996
  6. Zain T, Grinkemeyer MD. Mycosis fungoides: Cutaneous T eel/ Am f'am Physician. 1991;43:1703-7
  7. Kirsch IR, Watanabe R, O'Malley JT, et al. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med. 2015;7:308158
  8. Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53:1053-63
  9. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713-22
  10. Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29:2598-607
  11. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-85
  12. Ahn CS, ALSayyah A, Sangueza OP. Mycosis fungoides: an updated review of clinicopathologic variants. Am J Dermatopathol. 2014;36:933-48
  13. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730-9
  14. Olsen EA, Rook AH, Zic J, et al. Sezary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lym phoma Consortium (USCLC). J A Acad Dermatol. 2011;64:352-404
  15. Kim EJ, Hess S, Richardson SK, e